Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 13, 2005. The report details corporate actions regarding share buybacks, treasury holdings, and changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on capital structure and equity transactions.
- Share Repurchase Price: 1,335.6 pence per share.
- Shares Purchased: 510,000 Ordinary Shares.
- Total Treasury Shares: 89,583,000 (post-transaction).
- Shares in Issue: 5,852,745,198 (excluding treasury shares).
- Director Share Purchase Price: £13.25 per share (via ShareReward Plan).
Material Changes
The primary material change reported is the reduction of outstanding shares through a treasury buyback and specific adjustments to director shareholdings.
- Treasury Holdings: Increased by 510,000 shares on May 13, 2005, bringing the total to 89,583,000.
- Employee Trust Transfer: The GSK Trust transferred 7,868 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991 on May 12, 2005.
- Director Acquisition: Director Mr. J S Heslop acquired 18 Ordinary Shares (9 personal, 9 company-matched) on May 11, 2005.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of shareholder authority granted at the Annual General Meeting on May 17, 2004, to purchase shares. The filing explicitly states that the announcement does not constitute an offer or solicitation to purchase securities in any jurisdiction. No forward-looking guidance, risk factors, or contingencies are disclosed in this specific report.
Investor Verification Checklist
- Verify the total number of shares in issue (5,852,745,198) against the company's latest capitalization table.
- Confirm the cumulative cost of the 510,000 shares purchased at 1,335.6 pence each.
- Review the remaining authority for share buybacks under the mandate granted on May 17, 2004.
- Check the total value of shares held in the GSK Trust following the transfer of 7,868 shares.